Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Common Stock · EUR · F
Price
€2.812
Cap
—
Earnings
—
30d Trend
+4.7%
37% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 67×Macro 0.99 (−1%)=66
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 80%
BRAIN47 HORIZON ANALYSIS
Long-term compounder — quality business with growth runway
BRAIN47'S ASSESSMENT
I rate Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited at 66/100 — a STRONG reading on the Brain47 Signal. The strongest factor is quality at 90/100. I classify this as a growth position with the strongest thesis on a long-term horizon.
PAST PERFORMANCE
1 MONTH
+2.5%
3 MONTHS
-5.6%
12 MONTHS
+69.3%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Long-term compounder — quality business with growth runway. Quality (90) and Momentum (85) are the primary strengths. Historical volatility is moderate at 37%. I classify this as a growth position — strong momentum combined with growth potential points to capital appreciation.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.